Hypokalemia is a common feature in patients with adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome (CS) (80–85% of patients) (Fan et al., 2020; Lacroix et al., 2015). This evidence concerns the gene POMC and Cushing syndrome due to macronodular adrenal hyperplasia.